IPDMS 2.0 - Integrated Pharma Database Management System

For any queries, please email us at nppa-ipdms[at]gov[dot]in or call on Helpline No. 1800111255 | For More Information Visit www[dot]nppa[dot]gov[dot]in

Services

FAQs

Help Desk

Services

Registration for companies

Pharma Sahi Daam / Lodge a Complaint

Status of request to show Work flow of all request made by Companies

Pharma Sahi Daam Grievance Tracking

Regulatory Compliance

Form for Retail price (Form I)

Form for Discontinuation (Form IV)

Forms submissions for Formulations (Form II, III, V)

Forms submissions for Medical Devices (Form III, VI)

NPPA

Ensuring Affordable
Healthcare
for All

More About NPPA

National Pharmaceutical Pricing Authority (NPPA)

National Pharmaceutical Pricing Authority (NPPA) was constituted vide Government of India Resolution dated 29th August, 1997 as an attached office of the Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers as an independent Regulator for pricing of drugs and to ensure availability and accessibility of medicines at affordable prices.

Regulating Prices

Regulating and monitoring the prices of Drugs and Medical devices under DPCO, 2013 like fixation of ceiling price of scheduled formulations, retail price of New Drug or fixation of prices under extraordinary circumstances.

Drug Price Control

Implement and enforce the provisions of the Drugs (Prices Control) Order in accordance with the powers delegated to it.

Monitoring Availability

Monitor the availability of drugs, identify shortages, if any, and to take remedial steps.

Monitoring Price

Monitor the prices of scheduled as well as non-scheduled medicines (including new drugs without price approval) under DPCO, 2013 and take appropriate action against companies found overcharging the consumers.

Ceiling Price

NPPA fixes the ceiling price of scheduled formulations. No manufacturer is permitted to sell it above ceiling price (plus applicable local taxes). At present, ceiling prices for 935 formulations have been fixed by NPPA.

Retail Price

NPPA also fixes retail prices for new drugs, as defined under para 2(1)(u) of DPCO, 2013. At present 3646 retail prices of new drugs have been fixed by NPPA.

Extraordinary Circumstances

Prices are also fixed in public interest under para 19 of DPCO, 2013 as and when required. In the past, Para 19 have been invoked for rationalising the prices of select non-scheduled anti-cancer drugs, six covid essential medical devices and knee implants.

Visit nppa.gov.in More

PMRU

Price Monitoring Resource Unit (PMRU) is an extended arm of NPPA which are registered as a society and functions under direct supervision of concerned State Drug Controller. Primary function of PMRUs is to assist NPPA in monitoring of prices of pharmaceutical drugs, ensuring their availability and raising consumer awareness. They act as collaborating partners of NPPA with information gathering mechanism at grass-roots level.

PMRU Activities

PMRU Activities

Ceiling Price fixed for Scheduled formulation

935

Retail Price Fixed for New Drug

3775

Entities Registered on IPDMS

3020

Price Monitoring Resource Unit

33

What's New

Utilities

Social media

NPPA E-Book

13th DPCO 2013 Amendment dated 30.06.2026 New

Compliance with para 21(1) of the DPCO, 2013 regarding submission of the Form III on a quarterly basis- reg.

Integration of Pharma Jan Samadhan Portal with Pharma Sahi Daam Portal for enhanced citizen services

Citizens Corner

FAQs

Guidelines issued from NPPA with Respect to Monitoring and Enforcement of Overcharging

PDF Internal Guidelines for Overcharging Cases dated 07.10.2016 PDF Discontinuation Guidelines PDF OM dated 24-11-2017 (New Drug) PDF O.M. dated 26.05.2017 - Violation of different provisions under DPCO 2013 by pharma companies PDF OM dated 01-02-2024 - New drugs launch without prior approval PDF O.M. dated 04-02-2025 on para 24 and 25 PDF OM dated 22-07-2025 reg inter-brand NS cases

Policies (Drugs and Medical Devices)

PDF National Medical Devices Policy, 2023 PDF National Pharmaceutical Pricing Policy, 2012

Grievances of Citizens (PSD) Webpage

Registration

PDF Letter dated 19.05.2015 PDF Letter dated 02.06.2015 PDF Notice dated 16.11.2015 PDF Notice dated 21.12.2015 PDF Notice dated 18.01.2016 PDF Notice dated 25.02.2016 PDF Notice dated 10.06.2016 PDF Notice dated 03.08.2016 PDF Office Memorandum (OM) dated 16.02.2017 PDF Office Memorandum (OM) dated 17.02.2017 PDF Notice dated 01.05.2017 PDF Office Memorandum (OM) dated 05.09.2017

Milestones

2013

Erstwhile, DPCO 1995 was replaced by DPCO 2013. Drug pricing methodology shifted from cost based to market based methodology

2014

Capped the MRP of 106 cardiac and anti-diabetic non-scheduled drugs under Para 19 of DPCO 2013

2015

Integrated Pharmaceutical Database Management System (IPDMS) was launched

2016

Schedule-I of DPCO 2013 was amended by incorporating NLEM 2015.

Ceiling prices of scheduled formulations are fixed under NLEM 2015

NPPA started uploading draft working sheet prior to its approval to ensure transparency

2017

Fixed the ceiling prices of coronary stents

Fixed the price of Knee Implants

2018

The ceiling of coronary stents were re-fixed

2019

The price of non-scheduled formulations of 42 anti-cancer drugs were capped based on Trade Margin Rationalization Approach

2020

NPPA implement Ecosystem with a view ensure timely disposal of applications

2021

The price of six medical devices were rationalized based on Trade Margin Rationalization approach

2022

Authority under DPCO 2013 conducted its 100th meeting

NPPA completed 25 years

View all

Medicine price checker
Brand and formulation search
Grievance related to medicine pricing

Scan QR for "Pharma Sahi Daam" Mobile Application

Scan QR to download Pharma Sahi Daam — opens Play Store on Android, App Store on iOS

Sl. No.	Particulars	Description
1	Name of the formulation
2	Name and address of the manufacturer / importer
3	Name of the Marketing Company, if any
4	Composition as per label claimed and approved by Drug Control Authorities
5	Drugs Control Authority Permission Number and Date (copy to be enclosed)
6	Ceiling Price (in Rs. per unit, excluding taxes) and date of notification
7	Applicable GST rate (in %)
8	Pack size
9	Existing maximum retail price (MRP) of pack including all taxes and its effective date
10	Therapeutic category as per NLEM
11	Date of commencement of production / import
12	Intended date of discontinuation
13	Reasons for discontinuation of production / import
14	Year-wise Production / Import during the last 5 years including current year (in quantity of packs)
15	Year-wise sale during the last 5 years including current year (in quantity of packs)
16	Whether any new drug, as defined under DPCO 2013, has been launched or intended to be launched. If so, the details thereof
17	Any other information relevant to discontinuation of scheduled formulation

Sl. No.	Name of the Product (Formulation and its dosage forms)	Composition, as approved by Drug Control Authorities	Pack Size	GST rate (in %)	WPI rate change w.r.t. preceding year (in %)	Price to retailer per pack (excluding taxes) (Rs.)		Maximum Retail Price (incl. of all taxes) (Rs.)		Notified Ceiling Price (in Rs., excluding taxes)	Batch no. and date from which price revision is effective
Sl. No.	Name of the Product (Formulation and its dosage forms)	Composition, as approved by Drug Control Authorities	Pack Size	GST rate (in %)	WPI rate change w.r.t. preceding year (in %)	Pre revised	Revised	Pre revised	Revised	Notified Ceiling Price (in Rs., excluding taxes)	Batch no. and date from which price revision is effective
(1)	(2)	(3)	(4)	(5)	(6)	(7)	(8)	(9)	(10)	(11)	(12)
Scheduled formulations
	Own Manufactured Formulations
	Purchased Formulations
	Imported Formulations

Name of the Scheduled Formulation	Composition / Strength	Dosage Form	Unit (No / kg / Ltr)	Production / Import Level					Domestic Sale
Name of the Scheduled Formulation	Composition / Strength	Dosage Form	Unit (No / kg / Ltr)	Previous Year	1st Quarter	2nd Quarter	3rd Quarter	4th Quarter	Previous Year	1st Quarter	2nd Quarter	3rd Quarter	4th Quarter
(1)	(2)	(3)	(4)	(5)	(6)	(7)	(8)	(9)	(10)	(11)	(12)	(13)	(14)

Name of the Bulk Drugs / APIs used in Scheduled Formulation	Unit (kg / Ltr)	Installed Capacity	Production / Import Level					Domestic Sale
Name of the Bulk Drugs / APIs used in Scheduled Formulation	Unit (kg / Ltr)	Installed Capacity	Previous Year	1st Quarter	2nd Quarter	3rd Quarter	4th Quarter	Previous Year	1st Quarter	2nd Quarter	3rd Quarter	4th Quarter
(1)	(2)	(3)	(4)	(5)	(6)	(7)	(8)	(9)	(10)	(11)	(12)	(13)

Sl. No.	Name of the Product (Formulation and its dosage forms)	Composition, as approved by Drug Control Authorities	Pack Size	GST rate (in %)	Price to Distributor (excluding taxes) (Rs.)	Price to retailer (excluding taxes) (Rs.)	Prerevised Maximum Retail Price, if any (incl. of all taxes) (Rs.)	Maximum Retail Price (incl. of all taxes) (Rs.)	Batch no. and date from which price revision is effective	Production capacity
(1)	(2)	(3)	(4)	(5)	(6)	(7)	(8)	(9)	(10)	(11)
Scheduled formulations
	Own Manufactured Formulations
	Purchased Formulations
	Imported Formulations

Sl. No.	Name of the Product (Formulation and its dosage forms)	Composition, as approved by Drug Control Authorities	Pack Size	GST rate (in %)	Price to Distributor (excluding taxes) (Rs.)	Price to retailer (excluding taxes) (Rs.)	Prerevised Maximum Retail Price, if any (incl. of all taxes) (Rs.)	Maximum Retail Price (incl. of all taxes) (Rs.)	Batch no. and date from which price revision is effective	Production capacity
(1)	(2)	(3)	(4)	(5)	(6)	(7)	(8)	(9)	(10)	(11)
Non-Scheduled formulations
	Own Manufactured Formulations
	Purchased Formulations
	Imported Formulations

Services

Regulatory Compliance

National Pharmaceutical Pricing Authority (NPPA)

Regulating Prices

Drug Price Control

Monitoring Availability

Monitoring Price

Ceiling Price

Retail Price

Extraordinary Circumstances

PMRU

PMRU Activities

PMRU Activities

PMRU Activities

PMRU Activities

PMRU Activities

PMRU Activities

935

3775

3020

33

NPPA E-Book

13th DPCO 2013 Amendment dated 30.06.2026 New

Compliance with para 21(1) of the DPCO, 2013 regarding submission of the Form III on a quarterly basis- reg.

Integration of Pharma Jan Samadhan Portal with Pharma Sahi Daam Portal for enhanced citizen services

FAQs

Guidelines issued from NPPA with Respect to Monitoring and Enforcement of Overcharging

Policies (Drugs and Medical Devices)

Grievances of Citizens (PSD) Webpage

Registration

Milestones

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

Scan QR for "Pharma Sahi Daam" Mobile Application

Open the IPDMS portal

Open the Login dialog

Fill the registration form

Provide mandatory identifiers

Save and receive credentials

5 types of change request a company can raise

Login to IPDMS 2.0

Open the Company Details section

Action → Request History

Login to IPDMS 2.0

Open Company Detail → Add Plant

Choose the plant type

Fill plant details and save

Process for filling forms in IPDMS portal